Product NDC: | 0206-8860 |
Proprietary Name: | Zosyn |
Non Proprietary Name: | PIPERACILLIN SODIUM and TAZOBACTAM SODIUM |
Active Ingredient(s): | 2; 250 g/50mL; mg/50mL & nbsp; PIPERACILLIN SODIUM and TAZOBACTAM SODIUM |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0206-8860 |
Labeler Name: | Pfizer Pharmaceuticals LLC, Pfizer Pharmaceutical LLC - Piperacillin |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050750 |
Marketing Category: | NDA |
Start Marketing Date: | 19980301 |
Package NDC: | 0206-8860-02 |
Package Description: | 24 BAG in 1 BOX (0206-8860-02) > 50 mL in 1 BAG (0206-8860-01) |
NDC Code | 0206-8860-02 |
Proprietary Name | Zosyn |
Package Description | 24 BAG in 1 BOX (0206-8860-02) > 50 mL in 1 BAG (0206-8860-01) |
Product NDC | 0206-8860 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | PIPERACILLIN SODIUM and TAZOBACTAM SODIUM |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19980301 |
Marketing Category Name | NDA |
Labeler Name | Pfizer Pharmaceuticals LLC, Pfizer Pharmaceutical LLC - Piperacillin |
Substance Name | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM |
Strength Number | 2; 250 |
Strength Unit | g/50mL; mg/50mL |
Pharmaceutical Classes | beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA] |